New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by

Stromedix raises $25mm in Series B for fibrosis programs
08 May 2008
Executive Summary
Stromedix (fibrotic disease therapeutics) has completed a $25mm Series B round led by New Leaf Venture Partners along with other new investors Bessemer Venture Partners and Red Abbey Venture Partners. Returning backers Atlas Venture and Frazier Healthcare Ventures also participated in the financing. New Leaf's Ron Hunt and Bessemer's Chris Gabrieli will join Stromedix's board.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com